| 产品描述: | Zolunicant (MM-110) is a potent inhibitor against nicotinic α3β4 receptors with an IC50 of 0.90 μM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse. Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis. |
| 体外研究: |
Zolunicant (18-MC; 0.01-100 μM) 对烟碱型 α3β4 受体具有抑制活性,IC50 为 0.90 μM。 。Zolunicant (18-MCOR; 0-20 μg/mL; 24 h) 还对 L. amazonensis 感染的巨噬细胞显示出抗鞭毛体活性。 |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.714 ml |
13.57 ml |
27.139 ml |
| 5 mM |
0.543 ml |
2.714 ml |
5.428 ml |
| 10 mM |
0.271 ml |
1.357 ml |
2.714 ml |
| 50 mM |
0.054 ml |
0.271 ml |
0.543 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |